Paul Matteis's
Stock Forecasts
22.22%
4/18 win trades
Price targets by Paul Matteis
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Neurogene Inc. NGNE | 10 months ago | $46 133.50% upside | $15.33 | StreetInsider | |
 Alkermes plc ALKS | 11 months ago | $36 24.13% upside | $26.59 | StreetInsider | |
 BioMarin Pharmaceutical Inc. BMRN | about 1 year ago | $115 101.75% upside | $93.84 | TheFly | |
 Alnylam Pharmaceuticals, Inc. ALNY | about 1 year ago | $295 -34.31% downside | $247.4 | StreetInsider | |
 Ionis Pharmaceuticals, Inc. IONS | about 1 year ago | $53 24.76% upside | $47.7 | TheFly | Previous targets (0) |
 Biogen Inc. BIIB | over 1 year ago | $275 98.19% upside | $225.21 | StreetInsider | Previous targets (0) |
 Dyne Therapeutics, Inc. DYN | over 1 year ago | $41 234.69% upside | $27.68 | StreetInsider | Previous targets (0) |
 Contineum Therapeutics, Inc. Class A Common Stock CTNM | over 1 year ago | $29 211.82% upside | $16 | StreetInsider | Previous targets (0) |
 Neumora Therapeutics, Inc. Common Stock NMRA | almost 2 years ago | $26 1475.66% upside | $10.91 | Benzinga | Previous targets (0) |
Other analysts covering same stocks
Andrew Galler
Wolfe Research
100%
win rate
Geoff Porges
Leerink Partners
100%
win rate
Maneka Mirchandaney
Evercore ISI
100%
win rate
Zhiqiang Shu
Berenberg Bank
66.67%
win rate
Steve Chesney
Atlantic Equities
60%
win rate
Olivia Brayer
Cantor Fitzgerald
60%
win rate
Charles Duncan
Cantor Fitzgerald
40%
win rate